Yanqun Shu - Concepedia

Author

Yanqun Shu

University of Minnesota

Also Known As

Yanqun Shu

Publications

349

Citations

H-Index

Concepts

All Affiliations

University of Minnesota Masonic Cancer Center University of Minnesota Medical Center Twin Cities Orthopedics NHS Blood and Transplant

About

Yanqun Shu is an author at University of Minnesota specializing in medicine, pharmacology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	162
2	Immunology	3	3	128
3	Pharmacology	3	3	128
4	Cell Biology	2	2	69
5	Biomolecular Engineering	1	1	35

Yanqun Shu

Publications

349

Citations

H-Index

Page 1

	Year	Citations
A Bispecific Recombinant Immunotoxin, DT2219, Targeting Human CD19 and CD22 Receptors in a Mouse Xenograft Model of B-Cell Leukemia/Lymphoma Daniel A. Vallera, D.A. Todhunter, David W. Kuroki, Clinical Cancer Research	2005	99
Design of a superior cytokine antagonist for topical ophthalmic use Jinzhao Hou, Sharon A. Townson, Joseph Kovalchin, Proceedings of the National Academy of Sciences Ocular DiseaseImmunologyImmune RegulationImmunologic MechanismInnate Immunity	2013	59
Increasing Anticarcinoma Activity of an Anti-erbB2 Recombinant Immunotoxin by the Addition of an Anti-EpCAM sFv B.J. Stish, Hua Chen, Yanqun Shu, Clinical Cancer Research	2007	44
Bioengineering a Unique Deimmunized Bispecific Targeted Toxin That Simultaneously Recognizes Human CD22 and CD19 Receptors in a Mouse Model of B-Cell Metastases Daniel A. Vallera, Seunguk Oh, Hua Chen, Molecular Cancer Therapeutics ImmunologyB LymphomaBiological TherapyImmunotherapySynthetic Immunology	2010	35
Molecular modification of a recombinant, bivalent anti-human CD3 immunotoxin (Bic3) results in reduced in vivo toxicity in mice Daniel A. Vallera, D.A. Todhunter, David W. Kuroki, Leukemia Research Molecular ImmunologyVivo ToxicityAutoimmune DiseaseMolecular ModificationImmunotoxicology	2004	34
A novel bispecific ligand-directed toxin designed to simultaneously target EGFR on human glioblastoma cells and uPAR on tumor neovasculature Alexander K. Tsai, Seunguk Oh, Hua Chen, Journal of Neuro-Oncology Drug TargetingMedicineHuman Glioblastoma CellsTumor NeovasculatureTumor Targeting	2010	34
A Bispecific Recombinant Cytotoxin (DTEGF13) Targeting Human Interleukin-13 and Epidermal Growth Factor Receptors in a Mouse Xenograft Model of Prostate Cancer B.J. Stish, Hua Chen, Yanqun Shu, Clinical Cancer Research	2007	34
Retroviral Immunotoxin Gene Therapy of Leukemia in Mice Using Leukemia-Specific T Cells Transduced with an Interleukin-3/Bax Fusion Protein Gene Daniel A. Vallera, Ni Jin, Yanqun Shu, Human Gene Therapy	2003	10

Page 1